Zydus Wellness Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
ZYDUSWELL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zydus Wellness Limited has submitted to BSE and NSE a consolidated set of disclosures from its promoters and promoter group members under SEBI Regulation 31(4). Each promoter entity and individual, including Zydus Lifesciences Limited, Zydus Family Trust, Pankaj R. Patel, Sharvil P. Patel, several HUFs, family trusts, LLPs and private limited companies, has declared that they have not created any encumbrance (such as pledging or hypothecation) on their equity shares of Zydus Wellness during the financial year ended March 31, 2025. Several members further clarified that they do not hold any shares of the company at all. The disclosures are signed by Pankaj R. Patel, Sharvil P. Patel, Dhaval N. Soni (Company Secretary of Zydus Lifesciences) and other designated partners/directors, mostly dated April 1-3, 2025, with one filing dated April 8, 2025.
This is a routine annual regulatory compliance filing and is neutral to mildly positive for shareholders, as it confirms that the promoter group has not pledged or otherwise encumbered their Zydus Wellness holdings during FY25. No new information on shareholding, business or finances is disclosed, so it is unlikely to move the stock price.